For Pfizer and Moderna, the COVID-19 vaccine boosters could be more profitable than the original doses because they won’t come with research and development costs. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.